A new study reveals that the use of psychedelic-assisted therapy for treating depression and anxiety shows promising early results, with participants reporting significant reductions in symptoms after just a single session. Researchers emphasize that these findings, while preliminary, suggest potential for psychedelics to offer rapid relief where traditional treatments have fallen short. The study highlights the need for further investigation into dosage, safety, and long-term effects before widespread adoption. Experts caution that more rigorous trials are required to fully understand the therapeutic benefits and risks.